CAM
Cormorant Asset Management’s Edgewise Therapeutics EWTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.7M | Buy |
4,251,992
+150,000
| +4% | +$1.97M | 4.15% | 6 |
|
|
2025
Q1 | $90.2M | Buy |
4,101,992
+695,458
| +20% | +$15.3M | 6.79% | 2 |
|
|
2024
Q4 | $91M | Hold |
3,406,534
| – | – | 5% | 5 |
|
|
2024
Q3 | $90.9M | Buy |
3,406,534
+400,000
| +13% | +$10.7M | 4.82% | 5 |
|
|
2024
Q2 | $54.1M | Hold |
3,006,534
| – | – | 3.13% | 9 |
|
|
2024
Q1 | $54.8M | Buy |
3,006,534
+454,545
| +18% | +$8.29M | 2.41% | 10 |
|
|
2023
Q4 | $27.9M | Sell |
2,551,989
-394,898
| -13% | -$4.32M | 1.33% | 21 |
|
|
2023
Q3 | $16.9M | Hold |
2,946,887
| – | – | 0.99% | 25 |
|
|
2023
Q2 | $22.8M | Hold |
2,946,887
| – | – | 1.28% | 24 |
|
|
2023
Q1 | $19.7M | Hold |
2,946,887
| – | – | 1.29% | 21 |
|
|
2022
Q4 | $26.3M | Sell |
2,946,887
-105,102
| -3% | -$940K | 1.76% | 17 |
|
|
2022
Q3 | $30M | Sell |
3,051,989
-798,011
| -21% | -$7.85M | 2.1% | 17 |
|
|
2022
Q2 | $30.6M | Sell |
3,850,000
-832,874
| -18% | -$6.63M | 2.32% | 11 |
|
|
2022
Q1 | $45.4M | Buy |
4,682,874
+1,116,973
| +31% | +$10.8M | 3.49% | 8 |
|
|
2021
Q4 | $54.5M | Buy |
3,565,901
+194,987
| +6% | +$2.98M | 3.24% | 8 |
|
|
2021
Q3 | $56M | Buy |
3,370,914
+230,000
| +7% | +$3.82M | 2.27% | 12 |
|
|
2021
Q2 | $66.5M | Buy |
3,140,914
+800,000
| +34% | +$16.9M | 2.26% | 10 |
|
|
2021
Q1 | $74.3M | Buy |
+2,340,914
| New | +$74.3M | 1.66% | 11 |
|